cells and breast tumor development microRNA 100 inhibits self-renewal of breast cancer stem-like

[1]  Peijing Zhang,et al.  miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion , 2014, PLoS genetics.

[2]  C. Gebeshuber,et al.  miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling , 2013, Oncogene.

[3]  Kevin Struhl,et al.  An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state , 2012, Proceedings of the National Academy of Sciences.

[4]  Ankit Malhotra,et al.  miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. , 2011, Cancer research.

[5]  T. Magnuson,et al.  The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels , 2011, Proceedings of the National Academy of Sciences.

[6]  T. Russo,et al.  miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  S. Weiss,et al.  MT1-MMP controls human mesenchymal stem cell trafficking and differentiation. , 2010, Blood.

[8]  Julia Schüler,et al.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.

[9]  M. Wicha.  Targeting breast cancer stem cells. , 2009, Breast.

[10]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[11]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[12]  Timothy D. Veenstra,et al.  Telomerase modulates Wnt signalling by association with target gene chromatin , 2009, Nature.

[13]  E. Feingold,et al.  Decreased expression of miR‐125b and miR‐100 in oral cancer cells contributes to malignancy , 2009, Genes, chromosomes & cancer.

[14]  M. Wicha,et al.  Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling , 2009, PLoS biology.

[15]  F. Bertucci,et al.  Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. , 2009, Cancer research.

[16]  S. Weiss,et al.  Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs , 2009, The Journal of cell biology.

[17]  I. Shih,et al.  The roles of human sucrose nonfermenting protein 2 homologue in the tumor-promoting functions of Rsf-1. , 2008, Cancer research.

[18]  Jae Hoon Kim,et al.  MicroRNA Expression Profiles in Serous Ovarian Carcinoma , 2008, Clinical Cancer Research.

[19]  William Ignace Wei,et al.  Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.

[20]  Masaomi Kato,et al.  microRNAs: small molecules with big roles –C. elegans to human cancer , 2008, Biology of the cell.

[21]  Michael J Kerin,et al.  MicroRNAs as Prognostic Indicators and Therapeutic Targets: Potential Effect on Breast Cancer Management , 2008, Clinical Cancer Research.

[22]  Huan Yang,et al.  MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. , 2008, Cancer research.

[23]  Peter Schirmacher,et al.  MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma , 2007, Hepatology.

[24]  J. Lieberman,et al.  let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells , 2007, Cell.

[25]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[26]  E. Wiemer.  The role of microRNAs in cancer: no small matter. , 2007, European journal of cancer.

[27]  J. M. Thomson,et al.  MicroRNA expression profiles in head and neck cancer cell lines. , 2007, Biochemical and biophysical research communications.

[28]  Qi Zhou,et al.  Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system. , 2007, Cancer research.

[29]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[30]  Max S Wicha,et al.  Cancer stem cells: an old idea--a paradigm shift. , 2006, Cancer research.

[31]  Ruth I. Tennen,et al.  Conditional telomerase induction causes proliferation of hair follicle stem cells , 2005, Nature.

[32]  M. Giel-Moloney,et al.  Functional proteomic screen identifies a modulating role for CD44 in death receptor-mediated apoptosis. , 2005, Cancer research.

[33]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[34]  J. Green.  Mouse models of human breast cancer: evolution or convolution? , 2003, Breast Cancer Research.

[35]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Chang,et al.  Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. , 2002, Molecular cancer therapeutics.

[37]  E. Chang,et al.  Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery. , 2002, Human gene therapy.

[38]  E. Chang,et al.  Systemic p53 Gene Therapy of Cancer with Immunolipoplexes Targeted by Anti-Transferrin Receptor scFv , 2001, Molecular medicine.

[39]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  E. Chang,et al.  Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[41]  J. August,et al.  Homotypic cell aggregation induced by anti-CD44(Pgp-1) monoclonal antibodies and related to CD44(Pgp-1) expression. , 1990, Journal of immunology.

[42]  V. Ambros,et al.  Escholarship@umms Program in Molecular Medicine Publications and Presentations Program in Molecular Medicine Drosophila Let-7 Microrna Is Required for Remodeling of the Neuromusculature during Metamorphosis Repository Citation , 2022 .

[43]  H. Ruohola-Baker,et al.  microRNA and stem cell function , 2007, Cell and Tissue Research.